AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 190 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $331,000 | -34.5% | 35,300 | -46.6% | 0.00% | -50.0% |
| Q2 2020 | $505,000 | +6.1% | 66,100 | -14.3% | 0.00% | -33.3% |
| Q1 2020 | $476,000 | -21.8% | 77,100 | +53.9% | 0.00% | 0.0% |
| Q4 2019 | $609,000 | -47.3% | 50,100 | -50.0% | 0.00% | 0.0% |
| Q3 2019 | $1,156,000 | +71.8% | 100,200 | +48.7% | 0.00% | 0.0% |
| Q2 2019 | $673,000 | +1.7% | 67,400 | +31.1% | 0.00% | 0.0% |
| Q1 2019 | $662,000 | +10.3% | 51,400 | +30.1% | 0.00% | 0.0% |
| Q4 2018 | $600,000 | -20.8% | 39,500 | +4.2% | 0.00% | 0.0% |
| Q3 2018 | $758,000 | -1.3% | 37,900 | -3.8% | 0.00% | 0.0% |
| Q2 2018 | $768,000 | -6.8% | 39,400 | -3.7% | 0.00% | -25.0% |
| Q1 2018 | $824,000 | +22.1% | 40,900 | -19.8% | 0.00% | +33.3% |
| Q4 2017 | $675,000 | -9.2% | 51,000 | +26.6% | 0.00% | 0.0% |
| Q3 2017 | $743,000 | -3.1% | 40,300 | -3.4% | 0.00% | 0.0% |
| Q2 2017 | $767,000 | -3.3% | 41,700 | +18.5% | 0.00% | 0.0% |
| Q1 2017 | $793,000 | -14.9% | 35,200 | +31.3% | 0.00% | -25.0% |
| Q4 2016 | $932,000 | +13.9% | 26,800 | -19.8% | 0.00% | 0.0% |
| Q3 2016 | $818,000 | -2.7% | 33,400 | -5.1% | 0.00% | 0.0% |
| Q2 2016 | $841,000 | +2.2% | 35,200 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $823,000 | -14.0% | 35,200 | +11.0% | 0.00% | -25.0% |
| Q4 2015 | $957,000 | +1.7% | 31,700 | +33.8% | 0.00% | 0.0% |
| Q3 2015 | $941,000 | +8.2% | 23,700 | +88.1% | 0.00% | 0.0% |
| Q2 2015 | $870,000 | -18.3% | 12,600 | -35.4% | 0.00% | -20.0% |
| Q1 2015 | $1,065,000 | +13.5% | 19,500 | -11.4% | 0.01% | +25.0% |
| Q4 2014 | $938,000 | -53.9% | 22,000 | -65.5% | 0.00% | -20.0% |
| Q3 2014 | $2,036,000 | +167.2% | 63,800 | +73.4% | 0.01% | +66.7% |
| Q2 2014 | $762,000 | +2.0% | 36,800 | -4.7% | 0.00% | 0.0% |
| Q1 2014 | $747,000 | -11.6% | 38,600 | +10.9% | 0.00% | -25.0% |
| Q4 2013 | $845,000 | -4.7% | 34,800 | -15.7% | 0.00% | 0.0% |
| Q3 2013 | $887,000 | -6.8% | 41,300 | -3.5% | 0.00% | 0.0% |
| Q2 2013 | $952,000 | – | 42,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
| Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
| Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
| March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
| Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
| AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
| CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
| Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |